KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Assets (2019 - 2025)

Historic Return on Assets for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.45%.

  • Vir Biotechnology's Return on Assets fell 1200.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.31% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Vir Biotechnology's Return on Assets stood at 0.45%, which was down 1200.0% from 0.44% recorded in Q2 2025.
  • Vir Biotechnology's Return on Assets' 5-year high stood at 0.5% during Q1 2022, with a 5-year trough of 0.45% in Q3 2025.
  • Its 5-year average for Return on Assets is 0.12%, with a median of 0.28% in 2023.
  • As far as peak fluctuations go, Vir Biotechnology's Return on Assets surged by 8900bps in 2022, and later crashed by -7100bps in 2023.
  • Vir Biotechnology's Return on Assets (Quarter) stood at 0.33% in 2021, then crashed by -44bps to 0.19% in 2022, then plummeted by -265bps to 0.31% in 2023, then decreased by -16bps to 0.36% in 2024, then decreased by -25bps to 0.45% in 2025.
  • Its Return on Assets was 0.45% in Q3 2025, compared to 0.44% in Q2 2025 and 0.43% in Q1 2025.